Working… Menu

Dabrafenib and/or Trametinib Rollover Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03340506
Recruitment Status : Recruiting
First Posted : November 13, 2017
Last Update Posted : October 21, 2021
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 20, 2027
Estimated Study Completion Date : December 21, 2027